The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

629 reports and counting

Updated daily with latest market intelligence
Fundraising
Graphite Bio

Graphite Bio Raises $238M in Series B

Graphite Bio, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $238M in Series B at a $1B valuation led by ARCH Venture Partners, Vida Ventures, Norwest Venture Partners, Samsara BioCapital.

Fundraising News Team
Apr 28, 2024
2 min read
Fundraising
Insitro

Insitro Raises $400M in Series D

Insitro, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $400M in Series D at a $2.8B valuation led by Blackstone, Canada Pension Plan Investment Board, Arch Venture Partners, Foresite Capital, GV, Andreessen Horowitz.

Fundraising News Team
Sep 8, 2024
2 min read
Fundraising
East West Bank

East West Bank Raises $10B in Public

East West Bank, a Banking company based in 135 North Los Robles Avenue, Pasadena, CA 91101, has raised $10B in Public at a $12B valuation led by Public.

Fundraising News Team
Jan 1, 2024
2 min read
Biotech
Graphite Bio

Graphite Bio raises $238M Series B at $1B valuation

Graphite Bio raises $238M in Series B at $1B valuation. Precision genetic medicines...

Editorial Team
Apr 28, 2024
1 min read$238M
Biotech
Insitro

Insitro raises $400M Series D at $2.8B valuation

Insitro raises $400M in Series D at $2.8B valuation. Machine learning for drug discovery...

Editorial Team
Sep 8, 2024
1 min read$400M
Biotech
Freenome

Freenome raises $290M Series D at $1.1B valuation

Freenome raises $290M in Series D at $1.1B valuation. AI-driven early cancer detection...

Editorial Team
Jan 23, 2024
1 min read$290M
Banking
East West Bank

East West Bank raises $10B Public at $12B valuation

East West Bank raises $10B in Public at $12B valuation. Bank subsidiary...

Editorial Team
Jan 1, 2024
1 min read$10B
Fundraising
Allogene Therapeutics

Allogene Therapeutics Raises $325M in Series E

Allogene Therapeutics, a Biotech company based in 210 East Grand Avenue, South San Francisco, CA 94080, has raised $325M in Series E at a $3.9B valuation led by TPG, Gilead Sciences, Pfizer, Frazier Healthcare Partners, University of California.

Fundraising News Team
Apr 15, 2024
2 min read
SaaS
SaaS Company 279

Where is SaaS Company 279's Headquarters? Main Office Location

SaaS Company 279's global headquarters is located at 279 Tech Drive, Atlanta, GA 90278. The office serves as the central hub for the company's SaaS operations.

Sarah Chen
Oct 4, 2024
2 min read
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.